BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
Topic

AstraZeneca's shot

Spain to trial mixing COVID vaccines after restricting AstraZeneca shot

Spain to trial mixing COVID vaccines after restricting AstraZeneca shot

Published 19 Apr, 2021 06:02pm
  • After decisions by various European public health authorities to suspend use of the AstraZeneca vaccine in under 60 year olds, we are setting out to urgently find scientific evidence to support decision making around possible alternatives.
  • "The study's objective is...to determine within 28 days whether a second dose of the Pfizer vaccine can be given to patients who have received the AstraZeneca vaccine," he said.
India AstraZeneca shot delay could be 'catastrophic' for Africa

India AstraZeneca shot delay could be 'catastrophic' for Africa

Published 01 Apr, 2021 05:47pm
  • India decided to delay big exports of the shots made in its territory by the Serum Institute of India (SII) to make sure it could meet local demand, two sources told Reuters last week.
  • The African Union had planned to vaccinate 20%-30% of the continent's population by the end of the year he said. "If the vaccines are delayed we are unlikely to meet our target," he added.
German experts recommend AstraZeneca vaccine only for over 60s

German experts recommend AstraZeneca vaccine only for over 60s

Published 30 Mar, 2021 09:52pm
*"After several consultations, STIKO, with the help of external experts, decided by a majority to recommend the AstraZeneca COVID-19 vaccine only for persons aged 60 years and older on the basis of available data on the occurrence of rare but very severe thromboembolic side effects," it said.
EU to further study blood clot cases linked to AstraZeneca's COVID-19 vaccine

EU to further study blood clot cases linked to AstraZeneca's COVID-19 vaccine

Published 25 Mar, 2021 08:25pm
  • External medical experts and two public representatives are expected to give their views on possible reasons for the clots, how they are occurring and other possible risks, the European Medicines Agency said.
  • The EMA and World Health Organization backed the vaccine's safety last week, but a poll showed European confidence had taken a hit after at least 17 countries suspended or delayed use following reports of hospitalisations with clotting issues and bleeding.
Denmark to extend suspension of AstraZeneca COVID shot amid doubts

Denmark to extend suspension of AstraZeneca COVID shot amid doubts

Published 25 Mar, 2021 05:45pm
  • Our basis for making a final decision on the further use of the COVID-19 vaccine by AstraZeneca is too uncertain.
  • "Many studies have been launched, but we do not yet have any conclusions. That is why we have decided to extend the suspension."
Canada changes tack, recommends use of AstraZeneca COVID-19 vaccine in people over 65

Canada changes tack, recommends use of AstraZeneca COVID-19 vaccine in people over 65

Updated 16 Mar, 2021 10:02pm
  • The National Advisory Committee on Immunization said it was basing its new guidelines on three recent real-world studies that examined the effectiveness of the vaccine.
  • The committee had said on March 1 that AstraZeneca doses should only be given to those aged from 18 to 64 because clinical trials had featured very few people 65 or older.
Loading...